Evidence map›Paper›PMID 42642367›Full record

ArticleNature communications2026

cellGeometry: ultra-fast single-cell deconvolution of bulk RNA-Seq using a geometric solution.

Rachel Lau, Cankut Çubuk, Athina Spiliopoulou, Pedro Martínez-Paz, Anna E A Surace, Liliane Fossati-Jimack, Soumya Raychaudhuri, Costantino Pitzalis, Myles J Lewis

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Rachel LauCentre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, and Barts NIHR Biomedical Research Centre & Barts Health NHS Trust, London, UK.ORCID http://orcid.org/0000-0002-8330-8048
Cankut ÇubukCentre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, and Barts NIHR Biomedical Research Centre & Barts Health NHS Trust, London, UK.ORCID http://orcid.org/0000-0003-4646-0849
Athina SpiliopoulouUsher Institute, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0002-5929-6585
Pedro Martínez-PazCentre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, and Barts NIHR Biomedical Research Centre & Barts Health NHS Trust, London, UK.ORCID http://orcid.org/0000-0002-5772-8153
Anna E A SuraceCentre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, and Barts NIHR Biomedical Research Centre & Barts Health NHS Trust, London, UK.ORCID http://orcid.org/0000-0001-9589-3005
Liliane Fossati-JimackCentre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, and Barts NIHR Biomedical Research Centre & Barts Health NHS Trust, London, UK.ORCID http://orcid.org/0000-0003-3757-3999
Soumya RaychaudhuriDivision of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-1901-8265
Costantino PitzalisCentre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, and Barts NIHR Biomedical Research Centre & Barts Health NHS Trust, London, UK.ORCID http://orcid.org/0000-0003-1326-5051
Myles J LewisCentre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, and Barts NIHR Biomedical Research Centre & Barts Health NHS Trust, London, UK. myles.lewis@qmul.ac.uk.ORCID http://orcid.org/0000-0001-9365-5345

Funding

Arthritis Research UK 20670Arthritis Research UK MT/23270RCUK | Medical Research Council (MRC) G0800648RCUK | Medical Research Council (MRC) MR/K015346/1RCUK | Medical Research Council (MRC) MR/ V012509/1
6 · The paper itself

Abstract

Single-cell analysis has rapidly expanded to produce cell atlases encompassing all human tissues. However, computational methods to deconvolute bulk samples using single-cell reference data have failed to keep pace with the increasing data size. Here we present cellGeometry, which uses non-negative geometric deconvolution (NGD), an intuitive vector projection method featuring non-negative matrix regularisation. Using matrix operations, cellGeometry scales to massive datasets and is ultrafast. Benchmarked using simulations from single-cell/nucleus RNA-Seq datasets with >3 million cells, cellGeometry is more accurate than existing methods and more robust against noise simulating different sequencing chemistries. It identifies outlying residual genes which may unveil pathogenic changes in gene expression and the presence of cell types absent from the reference. cellGeometry's flexible architecture allows merging of single-cell reference signatures to expand the range of cell types being deconvoluted. Validated against real bulk RNA blood and tissue samples, cellGeometry produces more accurate and realistic results.

Indexed as

RNA-SeqSequence Analysis, RNASingle-Cell AnalysisAlgorithmsGene Expression ProfilingHumansRNASingle-Cell Gene Expression AnalysisRNA

Identifiers

PMID42642367
PMCPMC13507090

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.